Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies

Experimental and Molecular Pathology

Volumn 77, Issue 1, 2004, Pages 1-6

  Holgersson, Åsa ^a   Nilsson, Anders ^a   Lewensohn, Rolf ^a   Kanter, Lena ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ALL; DNA PK; Ki 67; Multiple myeloma; Non Hodgkin's lymphoma

Indexed keywords

DNA; KU ANTIGEN; KU86 PROTEIN; PROTEIN DERIVATIVE; PROTEIN KINASE C; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPH NODE; LYMPHATIC SYSTEM TUMOR; MULTIPLE MYELOMA; PROTEIN CONTENT; PROTEIN EXPRESSION; SAMPLING; STAINING;

ANTIGENS, NUCLEAR; CELL COUNT; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOBLOTTING; KI-67 ANTIGEN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPH NODES; LYMPHOPROLIFERATIVE DISORDERS; MULTIPLE MYELOMA; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES;

EID: 3042547739     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2004.02.001     Document Type: Article

References (21)

1. Anderson C.W., Lees-Miller S.P. The nuclear serine/threonine protein kinase DNA-PK. Crit. Rev. Eukaryot. Gene Expr. 2:1992;283-314
2. Blunt T., Finnie N.J., Taccioli G.E., Smith G.C., Demengeot J., Gottlieb T.M., Mizuta R., Varghese A.J., Alt F.W., Jeggo P.A. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell. 80:1995;813-823
3. Bogue M.A., Zhu C., Aguilar-Cordova E., Donehower L.A., Roth D.B. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev. 10:1996;553-565
4. Bosma M.J., Carroll A.M. The SCID mutant: definition, characterization, and potential uses. Annu. Rev. Immunol. 9:1991;323-350
5. Casellas R., Nussenzweig A., Wuerffel R., Pelanda R., Reichlin A., Suh H., Qin X.F., Besmer E., Kenter A., Rajewsky K., Nussenzweig M.C. Ku80 is required for immunoglobulin isotype switching. EMBO J. 17:1998;2404-2411
6. Eriksson Å., Lewensohn R., Nilsson A. Expression and activity of DNA-dependent protein kinase in normal human leukocytes. Anticancer Res. 20:2000;3051-3058
7. Eriksson Å., Lewensohn R., Larsson R., Nilsson A. DNA-dependent protein kinase in leukaemia cells and correlation with drug sensitivity. Anticancer Res. 22:2002;1787-1794
8. Guidos C.J., Williams C.J., Grandal I., Knowles G., Huang M.T.F., Danska J.S. V(D)J recombination activates a p53-dependent DNA damage checkpoint in SCID lymphocyte precursors. Genes Dev. 10:1996;2038-2054
9. Kim S.H., Um J.H., Dong-Won B., Kwon B.H., Kim D.W., Chung B.S., Kang C.D. Potentiation of chemosensitivity in multidrug-resistant human leukaemia CEM cells by inhibition of DNA-dependent protein kinase using wortmannin. Leuk. Res. 24:2000;917-925
10. Lees-Miller S.P., Anderson C.W. The DNA-activated protein kinase, DNA-PK: a potential coordinator of nuclear events. Cancer Cells. 3:1991;341-346
11. Manis J.P., Dudley D., Kaylor L., Alt F.W. IgH switch recombination to IgG1 in DNA-PKcs-deficient B-cells. Immunity. 16:2002;607-617
12. Mimori T., Hardin J.A. Mechanism of interaction between Ku protein and DNA. J. Biol. Chem. 261:1986;10375-10379
13. Moll U., Lau R., Sypes M.A., Gupta M.M., Anderson C.W. DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues. Oncogene. 18:1999;3114-3126
14. Muller C., Christodoulopoulos G., Salles B., Panasci L. DNA-dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukaemia lymphocytes to nitrogen mustards. Blood. 92:1998;2213-2219
15. Nacht M., Strasser A., Chan Y.R., Harris A.W., Schlissel M., Bronson R.T., Jacks T. Mutations in the p53 and SCID genes cooperate in tumourigenesis. Genes Dev. 10:1996;2055-2066
16. Roth D.B., Menetski J.P., Nakajima P.B., Bosma M.J., Gellert M. V(D)J recombination: broken DNA molecules covalently sealed (hairpin) coding ends in scid mouse thymocytes. Cell. 70:1992;983-991
17. Roth D.B., Zhu C., Gellert M. Characterization of broken DNA molecules associated with V(D)J recombination. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10788-10792
18. Roth D.B., Lindahl T., Gellert M. Repair and recombination. How to make ends meet. Curr. Biol. 5:1995;496-499
19. Schlissel M., Constantinescu A., Morrow T., Baxter M., Peng A. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′-phosphorylated, RAG-dependent, and cell cycle regulated. Genes Dev. 7:1993;2520-2532
20. Taccioli G.E., Alt F.W. Potential targets for autosomal SCID mutations. Curr. Opin. Immunol. 7:1992;436-440
21. Vanasse G.J., Halbrook J., Thomas S., Burgess A., Hoekstra M.F., Disteche C.M., Willerford D.M. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. J. Clin. Invest. 103:1999;1669-1675